About CN Creative
CN Creative is a company based in Manchester (United Kingdom) founded in 2008 by Chris Lord was acquired by British American Tobacco in December 2012.. CN Creative has raised $3.1 million across 1 funding round from investors including British American Tobacco and Advent Life Sciences.
- Headquarter Manchester, United Kingdom
- Founders Chris Lord
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.1 M (USD)
in 1 rounds
-
Latest Funding Round
$3.1 M (USD), Series A
Jan 26, 2012
-
Investors
British American Tobacco
& 1 more
-
Employee Count
Employee Count
-
Acquired by
British American Tobacco
(Dec 19, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CN Creative
CN Creative has successfully raised a total of $3.1M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.1 million completed in January 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.1M
-
First Round
First Round
(26 Jan 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2012 | Amount | Series A - CN Creative | Valuation | Advent Life Sciences |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CN Creative
CN Creative has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include British American Tobacco and Advent Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and mid-stage life science focused VC firm investing in the US and Europe
|
Founded Year | Domain | Location | |
|
Manufacturer of multi-category tobacco products
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CN Creative
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CN Creative
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cn Creative Comparisons
Competitors of CN Creative
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CN Creative
When was CN Creative founded?
CN Creative was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Where is CN Creative located?
CN Creative is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Is CN Creative a funded company?
CN Creative is a funded company, having raised a total of $3.1M across 1 funding round to date. The company's 1st funding round was a Series A of $3.1M, raised on Jan 26, 2012.
What does CN Creative do?
CN Creative was founded in 2008 by Chris Lord and is based in Manchester, United Kingdom. Operations are centered in the creative sector, with the domain cncbio.com indicating possible ties to specialized fields. Specific services and industry details remain limited in available records. The company has been active since inception, led by its founder as the key personnel. Further operational insights are not documented.
Who are CN Creative's investors?
CN Creative has 2 investors. Key investors include British American Tobacco, and Advent Life Sciences.